Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1048)
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
8,098
Price
$28.04
Total Value
$227.07K
Shares Held After
1,596,423
% of Holdings
0.5%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
311
Price
$43.95
Total Value
$13.67K
Shares Held After
113,238
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
22,500
Price
$43.95
Total Value
$988.88K
Shares Held After
432,886
% of Holdings
4.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
2,076
Price
$43.95
Total Value
$91.24K
Shares Held After
105,211
% of Holdings
1.9%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
310
Price
$43.95
Total Value
$13.62K
Shares Held After
118,658
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
2,763
Price
$43.95
Total Value
$121.43K
Shares Held After
115,474
% of Holdings
2.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
17,244
Price
$18.18
Total Value
$313.50K
Shares Held After
1,136,810
% of Holdings
1.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
428
Price
$18.18
Total Value
$7.78K
Shares Held After
7,962
% of Holdings
5.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
43,621
Price
$18.18
Total Value
$793.03K
Shares Held After
4,883,494
% of Holdings
0.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
21,926
Price
$18.18
Total Value
$398.61K
Shares Held After
1,549,288
% of Holdings
1.4%
GYRE THERAPEUTICS, INC. (GYRE)
Luo Ying — Director
Shares
179
Price
$8.01
Total Value
$1.43K
Shares Held After
2,575,362
% of Holdings
0.0%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.10
Total Value
$1.00M
Shares Held After
1,398,095
% of Holdings
1.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
6,860
Price
$0.69
Total Value
$4.73K
Shares Held After
1,672,470
% of Holdings
0.4%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
129
Price
$1.70
Total Value
$219.30
Shares Held After
829
% of Holdings
15.6%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,679
Price
$16.00
Total Value
$26.86K
Shares Held After
3,622
% of Holdings
31.7%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.52
Total Value
$105.60K
Shares Held After
6,199,863
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$51.83
Total Value
$1.04M
Shares Held After
2,231
% of Holdings
90.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
35,101
Price
$14.00
Total Value
$491.26K
Shares Held After
779,784
% of Holdings
4.5%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
968
Price
$29.00
Total Value
$28.07K
Shares Held After
366,820
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
9,935
Price
$28.12
Total Value
$279.37K
Shares Held After
367,788
% of Holdings
2.6%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
963
Price
$29.00
Total Value
$27.93K
Shares Held After
268,261
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
10,132
Price
$28.12
Total Value
$284.91K
Shares Held After
269,224
% of Holdings
3.6%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
931
Price
$29.00
Total Value
$27.00K
Shares Held After
374,549
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,645
Price
$28.12
Total Value
$271.22K
Shares Held After
375,480
% of Holdings
2.5%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
928
Price
$29.00
Total Value
$26.91K
Shares Held After
1,604,521
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
9,544
Price
$28.12
Total Value
$268.38K
Shares Held After
1,605,449
% of Holdings
0.6%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
2,174
Price
$46.65
Total Value
$101.42K
Shares Held After
113,549
% of Holdings
1.9%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — CHIEF COMMERCIAL OFFICER
Shares
2,174
Price
$46.65
Total Value
$101.42K
Shares Held After
140,684
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
2,174
Price
$46.65
Total Value
$101.42K
Shares Held After
107,287
% of Holdings
2.0%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
2,181
Price
$46.65
Total Value
$101.74K
Shares Held After
118,968
% of Holdings
1.8%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
4,500
Price
$46.65
Total Value
$209.93K
Shares Held After
37,500
% of Holdings
10.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
829
Price
$581.68
Total Value
$482.21K
Shares Held After
40,513
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
504
Price
$580.22
Total Value
$292.43K
Shares Held After
41,342
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
678
Price
$579.37
Total Value
$392.81K
Shares Held After
41,846
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,653
Price
$578.48
Total Value
$956.23K
Shares Held After
42,524
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,217
Price
$577.39
Total Value
$702.69K
Shares Held After
44,177
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
250
Price
$576.55
Total Value
$144.14K
Shares Held After
45,394
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$575.38
Total Value
$391.26K
Shares Held After
45,644
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,267
Price
$574.31
Total Value
$727.65K
Shares Held After
46,324
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
677
Price
$573.46
Total Value
$388.23K
Shares Held After
47,591
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$572.17
Total Value
$446.29K
Shares Held After
48,268
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
445
Price
$571.12
Total Value
$254.15K
Shares Held After
49,048
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$570.41
Total Value
$136.90K
Shares Held After
49,493
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$569.01
Total Value
$136.56K
Shares Held After
49,733
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$567.27
Total Value
$22.69K
Shares Held After
49,973
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
2,403
Price
$18.03
Total Value
$43.33K
Shares Held After
1,154,054
% of Holdings
0.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
60
Price
$18.03
Total Value
$1.08K
Shares Held After
8,390
% of Holdings
0.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
6,081
Price
$18.03
Total Value
$109.64K
Shares Held After
4,927,115
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
3,056
Price
$18.03
Total Value
$55.10K
Shares Held After
1,571,214
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
68
Price
$158.11
Total Value
$10.75K
Shares Held After
1,666
% of Holdings
3.9%
Showing 401–450 of 1048 transactions (page 9 of 21)